As many as 71% of cough-cold sufferers in search of decongestant relief oppose a prescription requirement for pseudoephedrine, according to a survey commissioned by the Asthma and Allergy Foundation of America released Monday.
The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday.
Influenza activity in the United States decreased across several indicators, the Centers for Disease Control and Prevention reported Friday, though the agency projected that illness rates for the season have not yet peaked.
An investigational schizophrenia drug appears effective in reducing agitation in patients with the disease, according to results of a late-stage clinical trial published in the British Journal of Psychiatry.
Rite Aid on Monday introduced its annual national education and prevention campaign against heart disease in observation of American Heart Month in February.
Advanced Vision Research on Monday announced results from a pilot trial published in the journal Cornea that demonstrated a reduction in dry-eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears Nutrition, an optimized blend of omega-3 oils.
The next chapter for CVS Caremark officially is under way as the company announced on Monday the next stage of its previously announced transition plan and officially named Larry Merlo, president and COO, as CEO, effective March. 1.
Shortly after the Pharmacy Providers of Oklahoma joined a group representing the nation's independent community pharmacies and their patients, another organization also has signed up.